In summary, APP gencDNA transcripts, including L-APP in plasma, may serve as blood biomarkers for Alzheimer's disease and detect the early clinical or pre-clinical stages of Alzheimer's disease. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.